Search Results
Highlights from the European Haematology Association Conference - Acute Myeloid Leukaemia (AML)
Highlights from the EHA Conference - Acute Lymphoblastic Leukaemia (ALL)
Highlights from the EHA Conference - Chronic Myeloid Leukaemia (CML)
Highlights in AML and MDS from EHA 2022
EHA and ASCO 2023 highlights: promising treatments in AML, MDS, and ALL
Highlights from EHA: in-person discussions & exciting updates
Highlights in leukemia research: MRD as a prognostic factor
Menin inhibitors in AML: providing options for patients with NPM1 mutation and KMT2A rearrangement
Looking forward to EHA 2021
International Symposium on Acute Leukemias: key messages from the 2019 meeting
AML immunotherapy: pre-clinical data to look forward to at ASH 2017
Treatment options for high-risk AML
